Cramer Highlights Market Opportunities with Buy and Sell Signals Points to Potential Upside SpaceX OpenAI Anthropic Could Surpass Berkshire Hathaway in FirstDay Trading Value Polymarket AI Economy Reshapes Labor Market BlueCollar Workers May Gain as WhiteCollar Entry Jobs Slow Senco Gold Q4 Profit Surges 151 on Strong Gold Prices and Robust Retail Sales AnheuserBusch InBev Shares Decline After Sales Miss Market Estimates BPRN Q1 2026 Earnings Strong EPS Beat Lifts Shares as Princeton Bancorp Delivers 091 Purple Biotech Q1 2025 Earnings DevelopmentStage Focus Drives Investor Sentiment Novanta NOVT Q1 2026 Earnings EPS Beat Falls Short of Stopping Stock Decline TECH Q1 2026 Earnings EPS Misses Estimates Amid Mixed Demand Signals VICR Q1 2026 Earnings EPS Surprises 1983 Above Estimates as Stock Declines Slightly Scilex Holding SCLX Surges 587 as Momentum Builds Toward Resistance KRAKacquisition Corp KRAQ Hovers Near Trust Value Amid Low Volume Trading Calamos Convertible and High Income Fund CHY Approaches Key Resistance After 189 Gain Credit Suisse High Yield Credit Fund DHY Slips 14 Support Levels in Focus Aurora Mobile JG Slides 895 Key Support Level Under Pressure Mastercard MA Holds Steady Near Midpoint of Range as Market Awaits Catalyst US Stocks Extend Record Run as Dell Surges on AI Optimism Cineverse Corp CNVS Q1 2026 Earnings EPS Beat With 3464 Surprise Revenue Not Disclosed EasyJet Faces Italian Competition Probe Over Alleged Unfair Baggage Pricing Practices Ranbir KapoorBacked Prime Focus Shares Gain 2 on Rs 82 Crore Q4 Profit Marking Strong Turnaround AMKR Q1 2026 Earnings Strong EPS Beat Amid Mixed Signals Stock Slightly Lower KKRS KKR Subordinated Notes Holds Near 1631 as Low Volatility Persists Support and Resistance Levels in Focus ALLY Q1 2026 Earnings EPS Surges Past Estimates on Strong Net Interest Income and Credit Performance Fortis Inc Q1 2026 Earnings EPS Slightly Below Estimates Amid Stable Utility Operations Cass Information Systems Inc CASS Q1 2026 Earnings EPS Beats Estimates by 595 Shares Edge Higher Monte Rosa Therapeutics GLUE Q1 2026 Earnings EPS Miss Highlights Ongoing ClinicalStage Costs Stock Gains Modestly WERN Q1 2026 Earnings Surprise Profitability Despite Persistent Freight Headwinds RDNT Q1 2026 Earnings EPS Misses Estimates Stock Gains Amid Broader Market Optimism COFS Q1 2026 Earnings EPS Surpasses Estimates by 55